Literature DB >> 10821290

The Charcot foot.

W Jeffcoate1, J Lima, L Nobrega.   

Abstract

AIMS: To review the clinical manifestations of the Charcot foot in diabetes mellitus, with particular reference to theories concerning aetiology.
METHODS: Systematic review of the published literature, searching for the keywords 'Charcot', 'foot and diabetes' and 'neuropathy' on Medline, as well as by examination of the references in recent published reviews.
CONCLUSIONS: The Charcot foot of diabetes mellitus is a common problem, and yet is not widely recognized by non-specialists. The failure of professionals to identify the condition in its early phases is probably largely responsible for the gross deformity which follows continued weight-bearing. The condition is confined to those with severe peripheral neuropathy. It is thought to result from three factors: motor neuropathy leading to the development of abnormal forces within the foot, subsequent disorganization of the foot as a result of associated osteopenia and progressive destruction from continued weight-bearing, enabled by reduced pain sensation. The cause of the osteopenia is not known, but it is associated with increased bone blood flow, which may be mainly the result of loss of sympathetic innervation. The importance of increased limb blood flow in the pathogenesis of the Charcot foot has been recognized for over a century. Paradoxically, the increased flow is associated with evidence of macrovascular disease, in that the prevalence of vascular calcification of pedal vessels approaches 90%. After an interval of many months, the condition tends to evolve: the increased blood flow lessens, the osteopenia is reduced and the disorganized bones become sclerotic. This tendency for the condition to evolve remains unexplained, since it would not be expected if the condition was caused solely by progressive denervation. As a result, it is suggested that another factor may be involved in the pathogenesis of the Charcot foot: an abnormal vasomotor reflex, analogous to reflex sympathetic dystrophy, occurring against a background of severe peripheral neuropathy. The resolution of the condition occurs because it is the reflex component of the hyperaemia which proves self-limiting.

Entities:  

Mesh:

Year:  2000        PMID: 10821290     DOI: 10.1046/j.1464-5491.2000.00233.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  12 in total

1.  Audit of acute Charcot's disease in the UK: the CDUK study.

Authors:  F L Game; R Catlow; G R Jones; M E Edmonds; E B Jude; G Rayman; W J Jeffcoate
Journal:  Diabetologia       Date:  2011-11-08       Impact factor: 10.122

Review 2.  Theories concerning the pathogenesis of the acute charcot foot suggest future therapy.

Authors:  William J Jeffcoate
Journal:  Curr Diab Rep       Date:  2005-12       Impact factor: 4.810

3.  MDCT assessment of CAD in type-2 diabetic subjects with diabetic neuropathy: the role of Charcot neuro-arthropathy.

Authors:  Riccardo Marano; Dario Pitocco; Enrico Di Stasio; Giancarlo Savino; Biagio Merlino; Carlo Trani; Federica Pirro; Claudia Rutigliano; Carolina Santangelo; Aurelian Costin Minoiu; Luigi Natale; Lorenzo Bonomo
Journal:  Eur Radiol       Date:  2015-07-03       Impact factor: 5.315

4.  Charcot osteoarthropathy in diabetes: A brief review with an emphasis on clinical practice.

Authors:  Evanthia Gouveri; Nikolaos Papanas
Journal:  World J Diabetes       Date:  2011-05-15

Review 5.  Is this bone infected or not? Differentiating neuro-osteoarthropathy from osteomyelitis in the diabetic foot.

Authors:  Anthony R Berendt; Benjamin Lipsky
Journal:  Curr Diab Rep       Date:  2004-12       Impact factor: 4.810

Review 6.  Update on Charcot neuroarthropathy.

Authors:  E B Jude; A J Boulton
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

Review 7.  Neuropathic osteoarthropathy with and without superimposed osteomyelitis in patients with a diabetic foot.

Authors:  Antonio Leone; Victor N Cassar-Pullicino; Alessia Semprini; Laura Tonetti; Nicola Magarelli; Cesare Colosimo
Journal:  Skeletal Radiol       Date:  2016-02-17       Impact factor: 2.199

8.  Charcot osteoarthropathy in type 2 diabetes persons presenting to specialist diabetes clinic at a tertiary care hospital.

Authors:  Bilal Bin Younis; Adeela Shahid; Rozina Arshad; Saima Khurshid; Junaid Masood
Journal:  BMC Endocr Disord       Date:  2015-06-12       Impact factor: 2.763

9.  Mortality risk of Charcot arthropathy compared with that of diabetic foot ulcer and diabetes alone.

Authors:  Min-Woong Sohn; Todd A Lee; Rodney M Stuck; Robert G Frykberg; Elly Budiman-Mak
Journal:  Diabetes Care       Date:  2009-02-05       Impact factor: 19.112

Review 10.  Charcot foot and ankle with osteomyelitis.

Authors:  Ryan Donegan; Bauer Sumpio; Peter A Blume
Journal:  Diabet Foot Ankle       Date:  2013-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.